Liquid Biopsies
Liquid Biopsies: A test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood or for pieces of DNA from tumor cells that are in the blood. A liquid biopsy may be used to help find cancer at an early stage. It may also be used to help plan treatment or to find out how well treatment is working or if cancer has come back. Being able to take multiple samples of blood over time may also help doctors understand what kind of molecular changes are taking place in a tumor.
-
MAY 14, 2020 3:00 PM CESTC.E. CREDITS
MAY 14, 2020 3:00 PM CESTIncreasing evidence suggests that targeted sequencing of cell free DNA (cfDNA) can provide a comprehensive molecular portrait of solid tumors. However, the concordance between tissue and cfD...Speaker: Nicola Normanno, MDPresented at: OncomineWorld: A Virtual NGS Education MeetingAPR 21, 2020 6:00 AM PDTC.E. CREDITS
APR 21, 2020 6:00 AM PDTThe versatility of standard PCR and qPCR is well known. Digital PCR is now taking this to a whole new level. The power of partitioning enables you to explore new frontiers which have been li...Speaker: Daniel Löfgren, MSc.Presented at: Genetics Virtual Week 2020Sponsored By: QIAGENAPR 15, 2020 9:00 AM PDT
APR 15, 2020 9:00 AM PDTDATE: April 15, 2020 TIME: 9:00am PT, 12:00pm ET We report a molecular assay, Methyl-HiC, that can simultaneously capture the chromosome conformation and DNA methylome in a cell. Methyl-HiC...Speaker: Yaping Liu, Ph.D.Sponsored By: Zymo ResearchMAR 31, 2020 9:00 AM PDTC.E. CREDITS
MAR 31, 2020 9:00 AM PDTDATE: March 31, 2020 TIME: 9:00am PT, 12:00pm ET HER2-positive breast cancer is a type of breast cancer caused by over-expression of a protein called human epidermal growth factor receptor 2...Speaker: Matteo Allegretti, PhDNOV 20, 2019 8:00 AM PSTC.E. CREDITS
NOV 20, 2019 8:00 AM PSTDATE: November 20, 2019TIME: 8:00am PST, 11:00EST, 4:00pm GMT, 5:00pm CET Even as next-generation sequencing (NGS) has become widely used, and the costs have been reduced, it re...Speaker: Stefanie Stepanow, Dr. rer natSponsored By: Cytiva (formerly GE Healthcare Life Sciences)OCT 10, 2019 1:30 PM PDTC.E. CREDITS
OCT 10, 2019 1:30 PM PDTMetastatic castration resistant prostate cancer (mCRPC) refractory to secondary hormonal treatments such as enzalutamide or abiraterone acetate are the most lethal of prostate cancers. In thi...Speaker: Tian Zhang, MD, MHSPresented at: Cancer Research & Oncology 2019OCT 10, 2019 12:00 PM PDTC.E. CREDITS
OCT 10, 2019 12:00 PM PDTTumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...Speaker: Ravindra Kolhe, MD, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: QIAGENOCT 10, 2019 10:30 AM PDTC.E. CREDITS
OCT 10, 2019 10:30 AM PDTOsteosarcoma (OS) is the most common bone tumor in pediatric and adolescent/young adult patients. Over the past three decades, significant improvements in the survival rates or therapeutic ap...Speaker: Troy McEachron, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: NanoString TechnologiesOCT 10, 2019 10:30 AM PDTC.E. CREDITS
OCT 10, 2019 10:30 AM PDTAccumulation of structural variations (SVs) across the genome is a known trigger factor for oncogenesis. Structural mutations have been clearly implicated in a number of cancers, most notably...Speaker: Sven Bocklandt, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: Bionano GenomicsOCT 10, 2019 9:00 AM PDTC.E. CREDITS
OCT 10, 2019 9:00 AM PDTCopy-number alterations and chromosomal translocations are widespread in cancer and frequently causing oncogenic mutations that drive tumorigenesis and therapy resistance. Despite their preva...Speaker: Cheng-Zhong Zhang, PhDPresented at: Cancer Research & Oncology 2019OCT 10, 2019 9:00 AM PDTC.E. CREDITS
OCT 10, 2019 9:00 AM PDTBlockade of CTLA-4 and PD-1, members of the B7/CD28 family, have proven to be the most successful cancer immunotherapies to date. While the current therapeutic focus remains on B7/CD28 family...Speaker: Anthony Persen, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: Bio-TechneOCT 09, 2019 12:00 PM PDTC.E. CREDITS
OCT 09, 2019 12:00 PM PDTThe introduction of robot-assisted surgical technology into urological practice, has introduced new horizons for reducing the morbidity and enhancing the efficacy of surgery. Open radical cys...Speaker: Khurshid Guru, MDPresented at: Cancer Research & Oncology 2019OCT 09, 2019 10:30 AM PDTC.E. CREDITS
OCT 09, 2019 10:30 AM PDTA subset of women with ovarian cancer will present with an apparently isolated adnexal mass. Many of these women will have early stage ovarian cancer with a relatively good prognosis. Unfortu...Speaker: Mitchel Hoffman, MDPresented at: Cancer Research & Oncology 2019APR 10, 2019 1:30 PM PDTC.E. CREDITS
APR 10, 2019 1:30 PM PDTThe exponential advents of advances in techniques and types of molecular diagnostic testing, and modifying strategies for these tests, are encouraging; but these evolutions simultaneously con...Speaker: Eugean Jiwanmall, MPH, MBAPresented at: Molecular Diagnostics 2019APR 10, 2019 1:30 PM PDTC.E. CREDITS
APR 10, 2019 1:30 PM PDTIntegration of technology is influencing practice in the clinical laboratory and treatment of patients in the clinical practice arena. As laboratories begin to move from a volume to value mod...Speaker: Elizabeth Marlowe, PhD, D(ABMM) , Joanna Sickler, MPH, MBAPresented at: Molecular Diagnostics 2019APR 10, 2019 1:30 PM PDTC.E. CREDITS
APR 10, 2019 1:30 PM PDTMyeloid leukemias encompass a group of different diseases that include myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). These diseases are d...Speaker: Véronique Laloux, PhD , Beate Litzenburger, PhDPresented at: Molecular Diagnostics 2019Sponsored By: QIAGENAPR 10, 2019 12:00 PM PDTC.E. CREDITS
APR 10, 2019 12:00 PM PDTDetermining which patients would derive clinical benefit from immunotherapy is a compelling clinical question. Biomarkers have been shown to predict therapy outcome in various types of cancer...Speaker: Shidong Jia, MD, PhDPresented at: Molecular Diagnostics 2019APR 10, 2019 12:00 PM PDTC.E. CREDITS
APR 10, 2019 12:00 PM PDTPersonalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and commun...Speaker: Tony Magliocco, MD , Keith Gligorich, PhDPresented at: Molecular Diagnostics 2019Sponsored By: IlluminaAPR 10, 2019 12:00 PM PDTC.E. CREDITS
APR 10, 2019 12:00 PM PDTThe prevailing philosophy in biological testing has been to focus on simple tests with easy to interpret information such as ELISA or lateral flow assays. At the same time, there has been a d...Speaker: Brett Goldsmith, PhDPresented at: Molecular Diagnostics 2019APR 10, 2019 10:30 AM PDTC.E. CREDITS
APR 10, 2019 10:30 AM PDTCRISPR-chip combines two powerful technologies ,CRISPR and Graphene, for rapid detection of nucleic acids. This talk will focus on design and fabrication of CRISPR-chip and its potential util...Speaker: Kiana Aran, PhDPresented at: Molecular Diagnostics 2019APR 10, 2019 10:30 AM PDTC.E. CREDITS
APR 10, 2019 10:30 AM PDTQIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present our clinical decision support solutions,...Speaker: Sheryl Elkin, PhD , Dan Richards, PhDPresented at: Molecular Diagnostics 2019Sponsored By: QIAGENAPR 10, 2019 10:30 AM PDTC.E. CREDITS
APR 10, 2019 10:30 AM PDTThe BRCA1 and BRCA2 genes represent the best examples of the modern understanding of cancer molecular genetics. Testing for germline and somatic mutations in BRCA 1/2 has gradually become com...Speaker: Anika Joecker, PhD , Jennifer Poitras, PhDPresented at: Molecular Diagnostics 2019Sponsored By: QIAGENAPR 10, 2019 9:00 AM PDTC.E. CREDITS
APR 10, 2019 9:00 AM PDTThe laboratory diagnosis of infectious diseases has traditionally relied on recovery of pathogens in cultures and for many infections, this approach remains the standard of care. The developm...Speaker: Esther Babady, PhDPresented at: Molecular Diagnostics 2019APR 10, 2019 9:00 AM PDTC.E. CREDITS
APR 10, 2019 9:00 AM PDTRegulatory requirements for verification and validation are complex and often cause confusion among clinical laboratorians, especially in regards to quantitative molecular assays. This presen...Speaker: Morgan Pence, PhD, D(ABMM)Presented at: Molecular Diagnostics 2019Sponsored By: DiaSorin Molecular LLC
MAY 14, 2020
3:00 PM CEST
C.E. CREDITS
MAY 14, 2020
3:00 PM CEST
Increasing evidence suggests that targeted sequencing of cell free DNA (cfDNA) can provide a comprehensive molecular portrait of solid tumors. However, the concordance between tissue and cfD...
Speaker:
Nicola Normanno, MD
Presented at: OncomineWorld: A Virtual NGS Education Meeting
APR 21, 2020
6:00 AM PDT
C.E. CREDITS
APR 21, 2020
6:00 AM PDT
The versatility of standard PCR and qPCR is well known. Digital PCR is now taking this to a whole new level. The power of partitioning enables you to explore new frontiers which have been li...
Speaker:
Daniel Löfgren, MSc.
Presented at: Genetics Virtual Week 2020Sponsored By: QIAGEN
APR 15, 2020
9:00 AM PDT
APR 15, 2020
9:00 AM PDT
DATE: April 15, 2020 TIME: 9:00am PT, 12:00pm ET We report a molecular assay, Methyl-HiC, that can simultaneously capture the chromosome conformation and DNA methylome in a cell. Methyl-HiC...
Speaker:
Yaping Liu, Ph.D.
Sponsored By: Zymo Research
MAR 31, 2020
9:00 AM PDT
C.E. CREDITS
MAR 31, 2020
9:00 AM PDT
DATE: March 31, 2020 TIME: 9:00am PT, 12:00pm ET HER2-positive breast cancer is a type of breast cancer caused by over-expression of a protein called human epidermal growth factor receptor 2...
Speaker:
Matteo Allegretti, PhD
NOV 20, 2019
8:00 AM PST
C.E. CREDITS
NOV 20, 2019
8:00 AM PST
DATE: November 20, 2019TIME: 8:00am PST, 11:00EST, 4:00pm GMT, 5:00pm CET Even as next-generation sequencing (NGS) has become widely used, and the costs have been reduced, it re...
Speaker:
Stefanie Stepanow, Dr. rer nat
Sponsored By: Cytiva (formerly GE Healthcare Life Sciences)
OCT 10, 2019
1:30 PM PDT
C.E. CREDITS
OCT 10, 2019
1:30 PM PDT
Metastatic castration resistant prostate cancer (mCRPC) refractory to secondary hormonal treatments such as enzalutamide or abiraterone acetate are the most lethal of prostate cancers. In thi...
Speaker:
Tian Zhang, MD, MHS
Presented at: Cancer Research & Oncology 2019
OCT 10, 2019
12:00 PM PDT
C.E. CREDITS
OCT 10, 2019
12:00 PM PDT
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
Speaker:
Ravindra Kolhe, MD, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: QIAGEN
OCT 10, 2019
10:30 AM PDT
C.E. CREDITS
OCT 10, 2019
10:30 AM PDT
Osteosarcoma (OS) is the most common bone tumor in pediatric and adolescent/young adult patients. Over the past three decades, significant improvements in the survival rates or therapeutic ap...
Speaker:
Troy McEachron, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: NanoString Technologies
OCT 10, 2019
10:30 AM PDT
C.E. CREDITS
OCT 10, 2019
10:30 AM PDT
Accumulation of structural variations (SVs) across the genome is a known trigger factor for oncogenesis. Structural mutations have been clearly implicated in a number of cancers, most notably...
Speaker:
Sven Bocklandt, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: Bionano Genomics
OCT 10, 2019
9:00 AM PDT
C.E. CREDITS
OCT 10, 2019
9:00 AM PDT
Copy-number alterations and chromosomal translocations are widespread in cancer and frequently causing oncogenic mutations that drive tumorigenesis and therapy resistance. Despite their preva...
Speaker:
Cheng-Zhong Zhang, PhD
Presented at: Cancer Research & Oncology 2019
OCT 10, 2019
9:00 AM PDT
C.E. CREDITS
OCT 10, 2019
9:00 AM PDT
Blockade of CTLA-4 and PD-1, members of the B7/CD28 family, have proven to be the most successful cancer immunotherapies to date. While the current therapeutic focus remains on B7/CD28 family...
Speaker:
Anthony Persen, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: Bio-Techne
OCT 09, 2019
12:00 PM PDT
C.E. CREDITS
OCT 09, 2019
12:00 PM PDT
The introduction of robot-assisted surgical technology into urological practice, has introduced new horizons for reducing the morbidity and enhancing the efficacy of surgery. Open radical cys...
Speaker:
Khurshid Guru, MD
Presented at: Cancer Research & Oncology 2019
OCT 09, 2019
10:30 AM PDT
C.E. CREDITS
OCT 09, 2019
10:30 AM PDT
A subset of women with ovarian cancer will present with an apparently isolated adnexal mass. Many of these women will have early stage ovarian cancer with a relatively good prognosis. Unfortu...
Speaker:
Mitchel Hoffman, MD
Presented at: Cancer Research & Oncology 2019
APR 10, 2019
1:30 PM PDT
C.E. CREDITS
APR 10, 2019
1:30 PM PDT
The exponential advents of advances in techniques and types of molecular diagnostic testing, and modifying strategies for these tests, are encouraging; but these evolutions simultaneously con...
Speaker:
Eugean Jiwanmall, MPH, MBA
Presented at: Molecular Diagnostics 2019
APR 10, 2019
1:30 PM PDT
C.E. CREDITS
APR 10, 2019
1:30 PM PDT
Integration of technology is influencing practice in the clinical laboratory and treatment of patients in the clinical practice arena. As laboratories begin to move from a volume to value mod...
Speaker:
Elizabeth Marlowe, PhD, D(ABMM)
,
Joanna Sickler, MPH, MBA
Presented at: Molecular Diagnostics 2019
APR 10, 2019
1:30 PM PDT
C.E. CREDITS
APR 10, 2019
1:30 PM PDT
Myeloid leukemias encompass a group of different diseases that include myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). These diseases are d...
Speaker:
Véronique Laloux, PhD
,
Beate Litzenburger, PhD
Presented at: Molecular Diagnostics 2019Sponsored By: QIAGEN
APR 10, 2019
12:00 PM PDT
C.E. CREDITS
APR 10, 2019
12:00 PM PDT
Determining which patients would derive clinical benefit from immunotherapy is a compelling clinical question. Biomarkers have been shown to predict therapy outcome in various types of cancer...
Speaker:
Shidong Jia, MD, PhD
Presented at: Molecular Diagnostics 2019
APR 10, 2019
12:00 PM PDT
C.E. CREDITS
APR 10, 2019
12:00 PM PDT
Personalized medicine driven by genomic-based treatments continues to increase in importance. Representatives from two distinct healthcare entities – a regional reference lab and commun...
Speaker:
Tony Magliocco, MD
,
Keith Gligorich, PhD
Presented at: Molecular Diagnostics 2019Sponsored By: Illumina
APR 10, 2019
12:00 PM PDT
C.E. CREDITS
APR 10, 2019
12:00 PM PDT
The prevailing philosophy in biological testing has been to focus on simple tests with easy to interpret information such as ELISA or lateral flow assays. At the same time, there has been a d...
Speaker:
Brett Goldsmith, PhD
Presented at: Molecular Diagnostics 2019
APR 10, 2019
10:30 AM PDT
C.E. CREDITS
APR 10, 2019
10:30 AM PDT
CRISPR-chip combines two powerful technologies ,CRISPR and Graphene, for rapid detection of nucleic acids. This talk will focus on design and fabrication of CRISPR-chip and its potential util...
Speaker:
Kiana Aran, PhD
Presented at: Molecular Diagnostics 2019
APR 10, 2019
10:30 AM PDT
C.E. CREDITS
APR 10, 2019
10:30 AM PDT
QIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present our clinical decision support solutions,...
Speaker:
Sheryl Elkin, PhD
,
Dan Richards, PhD
Presented at: Molecular Diagnostics 2019Sponsored By: QIAGEN
APR 10, 2019
10:30 AM PDT
C.E. CREDITS
APR 10, 2019
10:30 AM PDT
The BRCA1 and BRCA2 genes represent the best examples of the modern understanding of cancer molecular genetics. Testing for germline and somatic mutations in BRCA 1/2 has gradually become com...
Speaker:
Anika Joecker, PhD
,
Jennifer Poitras, PhD
Presented at: Molecular Diagnostics 2019Sponsored By: QIAGEN
APR 10, 2019
9:00 AM PDT
C.E. CREDITS
APR 10, 2019
9:00 AM PDT
The laboratory diagnosis of infectious diseases has traditionally relied on recovery of pathogens in cultures and for many infections, this approach remains the standard of care. The developm...
Speaker:
Esther Babady, PhD
Presented at: Molecular Diagnostics 2019
APR 10, 2019
9:00 AM PDT
C.E. CREDITS
APR 10, 2019
9:00 AM PDT
Regulatory requirements for verification and validation are complex and often cause confusion among clinical laboratorians, especially in regards to quantitative molecular assays. This presen...
Speaker:
Morgan Pence, PhD, D(ABMM)
Presented at: Molecular Diagnostics 2019Sponsored By: DiaSorin Molecular LLC
- Cancer Diagnostics
- Cancer Research
- Molecular Diagnostics
- Biomarkers
- Molecular Biology
- Cancer Therapeutics
- Genetics
- Next-Generation Sequencing
- Genomics
- Oncology
- DNA Sequencing
- Clinical Diagnostics
- DNA
- Gene Sequencing
- Clinical Research
- Biotechnology
- Cell Biology
- Gene Expression
- PCR/RT-PCR/Real-time PCR
- Immunology
- Clinical Oncology
- Immuno-Oncology
- Laboratory Testing
- Gene Therapy
- Antibodies
- Diagnostics
- Cell Culture
- Precision Medicine
- Infectious Disease
- Bioinformatics
- Biochemistry
- Microbiology
- Stem Cell Technologies
- Assay Development
- Gene Editing
- Genotyping
- Cell Signaling / Transduction
- Epigenetics
- Pathology
- Drug Discovery
- CRISPR-Cas9
- Medicine
- Podiatry
- Opthalmology
- Pulmonology
- Nanotechnology
- Neonatology
- HIV
- Marine Biology
- Nursing
- Quality Control/Assurance
- Botany
- Rheumatology
- Cannabis Sciences
- Anesthetics
- RNAi Technologies
- Microbiome
- Proteomics
- Manufacturing
- Nephrology
- Allergy
- Embryology
- Personalized Healthcare
- LIMS
- Earth Sciences
- Intensive Care
- Gene Transfer
- Biobanking
- Parasitology
- Geriatrics
- Neuroscience
- Clinical Chemistry
- Transfusion Medicine
- DNA Synthesis
- Systems Biology
- Hematology
- Biomedical Engineering
- LC/GC
- Ecology
- Forensics
- CRISPR
- Cloning
- Spectroscopy
- High Throughput Screening
- Mass Spectrometry
- Electrophoresis
- Virology
- Developmental Biology
- Neurology
- Veterinary Sciences
- Cardiology
- Emergency Medicine
- Lab Automation
- Zoology
- Rare Diseases
- Anatomy
- Endocrinology
- Robotics
- Bioethics
- Urology
- Diabetes
- Epidemiology
- Pharmacology
- Animal Diets
- General Medicine
- Social Sciences
- Radiology
- Toxicology
- Agricultural Sciences
- Plant Sciences
- Chromatography
- Protein Chemistry
- Chemistry
- Hepatology
- Lab Animals
- Gastroenterology
- Analytical Chemistry
- Point of Care
- Nutrition
- Healthcare IT
- Animal Models
- Gynecology
- Marketing
- Animal Sciences
- Pediatrics
- Animal Behavior
- Physics
- Red Blood Cells
- Bioanalysis
- Bioassay
- Cancer
- Cell
- Research
- Liquid Biopsy
- Disease
- Research and Development
- Tumor
- Molecular Genetics
- Sequencing
- Clinical Genetics
- ALK
- Mechanobiology
- Microtubules
- Clinical Medicine
- University
- Cancer Biomarker
- Cancer Biology
- Ultrasound
- Cancer Cell
- Gene
- Laboratory
- Cancer Genomics
- Science
- Therapy
- T-Cells
- Genetic Testing
- Clinical Laboratory
- Body Fluid
- Technology
- Biology
- Tumor Markers
- Lung Cancer
- Blood Collection
- Circulating Tumor DNA (ctDNA)
- Genomic Testing
- Radiation
- Health
- Webinars
- General Laboratory
- Brain
- Exosomes
- Human Papillomavirus HPV
- Radiation Oncology
- Cancer Treatment
- Publishing
- Blood Cancer
- Treatment of Cancer
- Drug Development
- Bioengineering
- Virus
- Blood
- Laboratory Medicine
- Protein
- Medical Genetics
- Carcinoma
- Data Science
- Diagnosis
- Organ Transplantation
- Colorectal
- Clinical Lab
- Neuron
- Hepatitis C Virus
- Molecular Techniques
- Pre-clinical Research
- Molecular Pathogenesis
- HPV
- Lungs
- Space
- Validation
- Molecular Pathology
- Pancreatic Cancer
- Medical Laboratory
- Case Study
- Glioma
- Hepatitis B
- Materials Engineering
- Cell Isolation
- Tissue Clearing
- Biomedical Research
- Wellness
- Molecular Microbiology
- Cancer Immunology
- T Cell
- Life Sciences
- Cell Therapy
- Sample Preparation
- Brain Health
- Human Biology
- Human Genetics
- Medical Technology
- Autoimmune Disease
- Engineering
- Pancreatitis
- Imaging
- Extraction
- Translational Research
- Personality
- microRNA
- Space Science
- Personalized Medicine
- Targeted Therapy
- Method Validation
- Alternative Medicine
- Molecular Immunology
- Biomedical Informatics
- Clinical Trials
- Microfluidics
- Mechanics
- Melanoma
- Molecular Pharmacology
- Mouse
- Ovarian Cancer
- Prostate Cancer
- Drug Safety
- Metastasis
- Health Technology
- Patient Safety